Related Experiment Videos
[Drug addicts and local anesthesia: completeness of analgesia and general side effects]
Tandlaegebladet
|February 1, 1984
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Shiga toxin-producing Escherichia coli: incidence and clinical features in a setting with complete screening of patients with suspected infective diarrhoea.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2017
A new pathogenicity island carrying an allelic variant of the Subtilase cytotoxin is common among Shiga toxin producing Escherichia coli of human and ovine origin.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2013
A verocytotoxin-producing E. coli outbreak with a surprisingly high risk of haemolytic uraemic syndrome, Denmark, September-October 2012.
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2013
Escherichia coli clonal group A causing bacteraemia of urinary tract origin.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2012
Clonality and virulence traits of Escherichia coli associated with haemorrhagic septicaemia in turkeys.
Avian pathology : journal of the W.V.P.A·2011
Characteristics of the enteroaggregative Shiga toxin/verotoxin-producing Escherichia coli O104:H4 strain causing the outbreak of haemolytic uraemic syndrome in Germany, May to June 2011.
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2011
[Hemangioma of the maxilla].
Tandlaegebladet·1992
[Lymphangioma of the tongue: case report and review of the literature].
Tandlaegebladet·1992
[Necrotizing sialometaplasia].
Tandlaegebladet·1992
Should we be monitoring patients on systemic dermatologic therapies for psychiatric adverse effects?: a proposed clinical framework.
The Journal of dermatological treatment·2026
Reconceptualizing Substance Use Disorders and Comorbidity: Moving Beyond Dual Diagnosis.
The Journal of nervous and mental disease·2026
Steered molecular dynamics and free-energy analysis of withanolide unbinding from tau kinases TTBK1 and GSK-3β.
Journal of biomolecular structure & dynamics·2026
Pain and Opioid Dose Reduction Based on Substance Use Disorder Status: Secondary Analysis from a Pragmatic Effectiveness Trial.
Journal of general internal medicine·2026